99878-46-3

Upstream product

• 1570-45-2 isonicotinic acid ethylester 
• 2398-37-0 3-methoxyphenyl bromide 
• 35854-37-6 4-(3-methoxybenzyl)pyridine 

Downstream Products

• 35854-37-6 4-(3-methoxybenzyl)pyridine 
• 78815-62-0 4-(3-methoxybenzyl)-1-methylpiperidine 
• 78815-50-6 4-(3-methoxybenzyl)-1-methylpyridinium iodide 
• 288157-98-2 4-[3-methoxybenzoyl]-1-methylpiperidine oxalate 
• 288157-97-1 4-[3-methoxybenzoyl]-1-methylpiperidine 
• 288157-96-0 [(3-methoxyphenyl)(1-methylpiperid-4-yl)]methanol 
• 288157-99-3 4-[3-hydroxybenzoyl]-1-methylpiperidine 
• 288157-94-8 C₁₉H₂₀FNO₄S*ClH 

Relevant academic research and scientific papers

Overcoming Electron-Withdrawing and Product-Inhibition Effects by Organocatalytic Aerobic Oxidation of Alkylpyridines and Related Alkylheteroarenes to Ketones

An organocatalyzed aerobic benzylic C-H oxidation of alkyl and aryl heterocycles has been developed. This transition metal-free method is able to overcome the electron-withdrawing effect as well as product-inhibition effects in heterobenzylic radical oxidation. A variety of ketones bearing N-heterocyclic groups could be prepared under relatively mild conditions with moderate to high yields.

5-HT1f agonist

The present invention relates to a compound of formula I and a process for making: or a pharmaceutical acid addition salt thereof; which are useful for activating 5-HT1Freceptors and inhibiting neuronal protein extravasation in a mammal.